Safety and effectiveness of follitropin alfa biosimilar to originator follitropin alfa in real-world clinical practice: A Multinational Comparative, Prospective Cohort Study

被引:0
|
作者
Kaplan, S. [1 ]
Levy-Toledano, R. [2 ]
Davies, M. [3 ]
Roy, D. [3 ]
Howles, C. [4 ]
Lass, A. [5 ]
机构
[1] Teva Pharmaceut Ind Ltd, Global Patient Safety & Pharmacovigilance, Netanya, Israel
[2] RLT Media, Consulting, Boulogne Billancourt, France
[3] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England
[4] Drug Safety Res Unit Southampton, Southampton, Hants, England
[5] Univ Edinburgh, Deanery Clin Sci, Coll Med & Vet Sci, Edinburgh, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-592
引用
收藏
页码:406 / 407
页数:2
相关论文
共 50 条
  • [1] Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
    Patel, Nayana Hitesh
    Patel, Niket H.
    Patel, Molina Niket
    Bhadarka, Harsha K.
    Vyas, Kairavi Sunilkumar
    [J]. JOURNAL OF HUMAN REPRODUCTIVE SCIENCES, 2023, 16 (02) : 148 - 155
  • [3] Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France
    Lehmann, Matthieu
    Arbo, Elisangela
    Pouly, Jean-Luc
    Barriere, Paul
    Boland, Lauren Amy
    Bean, Samuel George
    Jenkins, Julian
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2024, 22
  • [4] A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
    Gizzo, Salvatore
    Garcia-Velasco, Juan A.
    Heiman, Franca
    Ripellino, Claudio
    Buehler, Klaus
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2016, 8 : 683 - 689
  • [5] Effectiveness and safety of follitropin alfa in infertile women using assisted reproductive technology in real-world clinical practice: a multicenter, prospective, open, non-interventional study
    Sydow, P.
    Schneidereit, R.
    Pribbernow, K.
    Keck, C.
    Wiegratz, I.
    [J]. HUMAN REPRODUCTION, 2017, 32 : 460 - 460
  • [6] Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study
    Kaplan, Sigal
    Levy-Toledano, Rachel
    Davies, Miranda
    Roy, Debabrata
    Howles, Colin M.
    Lass, Amir
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [7] A letter to editor - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France."
    Schwarze, Juan-Enrique
    Chaudhari, Vivek
    Montenegro, Susana
    Castello-Bridoux, Claire
    Masseria, Cristina
    Roeder, Claudia
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2024, 23
  • [8] Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions
    Manzi, Lucio
    Sepe, Nunzio
    Migliaccio, Walter
    Lanzoni, Ludovica
    Iozzino, Luisa
    D'Angelo, Fabrizia
    Colarusso, Lucia
    Montenegro, Susana
    Palmese, Angelo
    D'Hooghe, Thomas
    Ulloa-Aguirre, Alfredo
    Koloda, Yulia
    Lispi, Monica
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [9] Safety of Ovaleap® (Follitropin Alfa) in infertile women undergoing superovulation for assisted reproductive technologies (SOFIA): A multinational comparative, prospective cohort study
    Kaplan, Sigal
    Toledano, Rachel
    Davies, Miranda
    Roy, Debabrata
    Howles, Colin
    Lass, Amir
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 334 - 334
  • [10] Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study
    Stoppa, Giovanna
    D'Amore, Carmen
    Conforti, Anita
    Traversa, Giuseppe
    Venegoni, Mauro
    Taglialatela, Maurizio
    Leone, Roberto
    [J]. BIODRUGS, 2018, 32 (04) : 367 - 375